Top Markets
#1 Islamic Coin Islamic Coin +152.33%
#2 Bitway Bitway +44.68%
#3 Starpower Starpower +39.27%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +32.03%
#5 aelf aelf +25.83%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.23%
#7 Pons Pons +22.58%
#8 SkyAI SkyAI +18.92%
#9 Ocean Protocol Ocean Protocol +16.20%
#10 Bedrock Bedrock +15.52%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
株式のランク #29651
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
株価
$0.68377137
最終同期: 2023-05-23
時価総額
$20.23M
変化（1日）
-0.60%
変化（1年）
0.00%
国
SE
取引 Medivir AB (publ) (MVIR-B)

カテゴリー

Healthcare
Medivir AB (publ)（MVIR-B）の利益
2026 時点の利益 TTM: 0
Medivir AB (publ) の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Medivir AB (publ) の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR